BOOTHBAY FUND MANAGEMENT, LLC - SATSUMA PHARMACEUTICALS INC ownership

SATSUMA PHARMACEUTICALS INC's ticker is STSA and the CUSIP is 80405P107. A total of 34 filers reported holding SATSUMA PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.

Quarter-by-quarter ownership
BOOTHBAY FUND MANAGEMENT, LLC ownership history of SATSUMA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2023$8,360
-22.4%
11,9680.0%0.00%
Q4 2022$10,771
-97.9%
11,968
-85.7%
0.00%
-100.0%
Q3 2022$501,000
+86.9%
83,468
+28.7%
0.01%
+85.7%
Q2 2022$268,000
+8.9%
64,8400.0%0.01%
+16.7%
Q1 2022$246,000
-15.8%
64,8400.0%0.01%
-14.3%
Q4 2021$292,000
-3.3%
64,8400.0%0.01%
-12.5%
Q3 2021$302,000
-49.6%
64,840
-23.6%
0.01%
-57.9%
Q2 2021$599,000
+21.5%
84,913
+1.7%
0.02%
+5.6%
Q1 2021$493,000
-39.5%
83,492
+194.5%
0.02%
-67.9%
Q2 2020$815,00028,3500.06%
Other shareholders
SATSUMA PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
COMMODORE CAPITAL LP 3,118,761$14,533,0003.83%
Ghost Tree Capital, LLC 904,225$4,214,0001.23%
RA Capital Management 5,914,252$27,560,0000.38%
Vivo Capital, LLC 1,232,394$5,743,0000.26%
Nan Fung Group Holdings Ltd 142,900$666,0000.21%
Ikarian Capital, LLC 629,384$2,934,0000.21%
NEA Management Company, LLC 3,142,958$14,646,0000.17%
SAMLYN CAPITAL, LLC 1,716,067$7,998,0000.11%
TPG Group Holdings (SBS) Advisors, Inc. 1,885,939$8,788,0000.09%
GSA CAPITAL PARTNERS LLP 90,665$422,0000.04%
View complete list of SATSUMA PHARMACEUTICALS INC shareholders